Open access
Jul 2026
The Role of Active Surveillance in Patients with Low-Risk Prostate Adenocarcinoma Harboring a Germline Brca2 Mutation: A Critical Discussion of Recent Evidence
As of 2026, AS may be considered in highly selected patients, but only after rigorous initial characterization with multiparametric MRI and appropriate biopsy assessment, clear patient counseling, and intensified follow-up.
Y. Alaoui, O. Bentaleb, S. Lafdali et al.
· Scholars Journal of Medical... · 0 citations